CN104280475B - 复方氨基酸(15)双肽(2)注射液氨基酸和甘氨酰谷氨酰胺含量检测方法 - Google Patents
复方氨基酸(15)双肽(2)注射液氨基酸和甘氨酰谷氨酰胺含量检测方法 Download PDFInfo
- Publication number
- CN104280475B CN104280475B CN201410604021.4A CN201410604021A CN104280475B CN 104280475 B CN104280475 B CN 104280475B CN 201410604021 A CN201410604021 A CN 201410604021A CN 104280475 B CN104280475 B CN 104280475B
- Authority
- CN
- China
- Prior art keywords
- solution
- sample
- amino acid
- acid
- mobile phase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 150000001413 amino acids Chemical class 0.000 title claims abstract description 82
- PNMUAGGSDZXTHX-BYPYZUCNSA-N Gly-Gln Chemical compound NCC(=O)N[C@H](C(O)=O)CCC(N)=O PNMUAGGSDZXTHX-BYPYZUCNSA-N 0.000 title claims abstract description 26
- 108010010147 glycylglutamine Proteins 0.000 title claims abstract description 24
- 238000000034 method Methods 0.000 title claims abstract description 20
- 238000002347 injection Methods 0.000 title claims abstract description 18
- 239000007924 injection Substances 0.000 title claims abstract description 18
- -1 compound amino acid Chemical class 0.000 title abstract description 7
- 108010016626 Dipeptides Proteins 0.000 title abstract description 4
- 239000000243 solution Substances 0.000 claims abstract description 47
- 239000007788 liquid Substances 0.000 claims abstract description 36
- 238000001514 detection method Methods 0.000 claims abstract description 16
- 239000002253 acid Substances 0.000 claims abstract description 12
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 10
- 238000010828 elution Methods 0.000 claims abstract description 10
- 238000010812 external standard method Methods 0.000 claims abstract description 8
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 claims abstract description 8
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 claims abstract description 7
- 239000003729 cation exchange resin Substances 0.000 claims abstract description 7
- 230000008929 regeneration Effects 0.000 claims abstract description 7
- 238000011069 regeneration method Methods 0.000 claims abstract description 7
- 238000006243 chemical reaction Methods 0.000 claims abstract description 6
- 238000001212 derivatisation Methods 0.000 claims abstract description 4
- 229940024606 amino acid Drugs 0.000 claims description 61
- 235000001014 amino acid Nutrition 0.000 claims description 61
- 239000000523 sample Substances 0.000 claims description 38
- 239000000872 buffer Substances 0.000 claims description 26
- 239000013558 reference substance Substances 0.000 claims description 26
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 20
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 18
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 18
- 238000012360 testing method Methods 0.000 claims description 17
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 16
- 238000007865 diluting Methods 0.000 claims description 15
- NIPYQLPZPLBOLF-UHFFFAOYSA-N 3'-hydroxy-6'-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyspiro[2-benzofuran-3,9'-xanthene]-1-one Chemical compound OC1C(O)C(O)C(CO)OC1OC1=CC=C2C3(C4=CC=CC=C4C(=O)O3)C3=CC=C(O)C=C3OC2=C1 NIPYQLPZPLBOLF-UHFFFAOYSA-N 0.000 claims description 12
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 11
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims description 10
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 10
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 10
- 239000004473 Threonine Substances 0.000 claims description 10
- 229960004295 valine Drugs 0.000 claims description 10
- 239000004475 Arginine Substances 0.000 claims description 9
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 9
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 9
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 9
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims description 9
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 9
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims description 9
- 238000004458 analytical method Methods 0.000 claims description 9
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 9
- 235000009697 arginine Nutrition 0.000 claims description 9
- 235000003704 aspartic acid Nutrition 0.000 claims description 9
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 9
- 235000013922 glutamic acid Nutrition 0.000 claims description 9
- 239000004220 glutamic acid Substances 0.000 claims description 9
- 229930182817 methionine Natural products 0.000 claims description 9
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims description 9
- 235000013930 proline Nutrition 0.000 claims description 9
- 235000004400 serine Nutrition 0.000 claims description 9
- 235000008521 threonine Nutrition 0.000 claims description 9
- RRNJROHIFSLGRA-JEDNCBNOSA-N acetic acid;(2s)-2,6-diaminohexanoic acid Chemical compound CC(O)=O.NCCCC[C@H](N)C(O)=O RRNJROHIFSLGRA-JEDNCBNOSA-N 0.000 claims description 8
- 235000004279 alanine Nutrition 0.000 claims description 8
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 8
- 229960005357 lysine acetate Drugs 0.000 claims description 8
- 239000000047 product Substances 0.000 claims description 7
- YASYEJJMZJALEJ-UHFFFAOYSA-N Citric acid monohydrate Chemical compound O.OC(=O)CC(O)(C(O)=O)CC(O)=O YASYEJJMZJALEJ-UHFFFAOYSA-N 0.000 claims description 6
- 229960002303 citric acid monohydrate Drugs 0.000 claims description 6
- 239000012467 final product Substances 0.000 claims description 6
- 239000012488 sample solution Substances 0.000 claims description 6
- 239000011734 sodium Substances 0.000 claims description 6
- 230000004407 detection of glutamine Effects 0.000 claims description 5
- DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 claims description 4
- 238000009795 derivation Methods 0.000 claims description 4
- 239000003085 diluting agent Substances 0.000 claims description 4
- 238000000926 separation method Methods 0.000 claims description 4
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 claims description 3
- 239000004327 boric acid Substances 0.000 claims description 3
- 229960004106 citric acid Drugs 0.000 claims description 3
- 238000011068 loading method Methods 0.000 claims description 3
- 230000003139 buffering effect Effects 0.000 claims description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims 1
- 150000002469 indenes Chemical class 0.000 claims 1
- 150000002576 ketones Chemical class 0.000 claims 1
- 239000003814 drug Substances 0.000 abstract description 3
- 239000007853 buffer solution Substances 0.000 abstract description 2
- 230000035945 sensitivity Effects 0.000 abstract description 2
- 238000001121 post-column derivatisation Methods 0.000 abstract 1
- 239000012088 reference solution Substances 0.000 abstract 1
- 125000000542 sulfonic acid group Chemical group 0.000 abstract 1
- 238000012795 verification Methods 0.000 abstract 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 11
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 10
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 10
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 9
- 229960005261 aspartic acid Drugs 0.000 description 9
- 229960002989 glutamic acid Drugs 0.000 description 9
- 229960004452 methionine Drugs 0.000 description 9
- 229960005190 phenylalanine Drugs 0.000 description 9
- 229960001153 serine Drugs 0.000 description 9
- 229960002898 threonine Drugs 0.000 description 9
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 8
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 8
- 229960003767 alanine Drugs 0.000 description 8
- 229960002885 histidine Drugs 0.000 description 8
- 229960000310 isoleucine Drugs 0.000 description 8
- 229960003136 leucine Drugs 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- 229960002429 proline Drugs 0.000 description 8
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 7
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 6
- 230000033228 biological regulation Effects 0.000 description 6
- 239000012490 blank solution Substances 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- XBGGUPMXALFZOT-VIFPVBQESA-N Gly-Tyr Chemical compound NCC(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 XBGGUPMXALFZOT-VIFPVBQESA-N 0.000 description 5
- XBGGUPMXALFZOT-UHFFFAOYSA-N glycyl-L-tyrosine hemihydrate Natural products NCC(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 XBGGUPMXALFZOT-UHFFFAOYSA-N 0.000 description 5
- 108010087823 glycyltyrosine Proteins 0.000 description 5
- 229910021529 ammonia Inorganic materials 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 239000004471 Glycine Substances 0.000 description 3
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 3
- 229930182816 L-glutamine Natural products 0.000 description 3
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 3
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 238000004364 calculation method Methods 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 3
- FEYJIFXFOHFGCC-UHFFFAOYSA-N 1-nitrohexane Chemical compound CCCCCC[N+]([O-])=O FEYJIFXFOHFGCC-UHFFFAOYSA-N 0.000 description 2
- IEFJWDNGDZAYNZ-BYPYZUCNSA-N Gly-Glu Chemical compound NCC(=O)N[C@H](C(O)=O)CCC(O)=O IEFJWDNGDZAYNZ-BYPYZUCNSA-N 0.000 description 2
- 108010002311 N-glycylglutamic acid Proteins 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 230000036571 hydration Effects 0.000 description 2
- 238000006703 hydration reaction Methods 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 239000012086 standard solution Substances 0.000 description 2
- 229960004799 tryptophan Drugs 0.000 description 2
- 238000010200 validation analysis Methods 0.000 description 2
- LOTKRQAVGJMPNV-UHFFFAOYSA-N 1-fluoro-2,4-dinitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(F)C([N+]([O-])=O)=C1 LOTKRQAVGJMPNV-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- HJCMDXDYPOUFDY-WHFBIAKZSA-N Ala-Gln Chemical compound C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(N)=O HJCMDXDYPOUFDY-WHFBIAKZSA-N 0.000 description 1
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UWTATZPHSA-N D-Serine Chemical compound OC[C@@H](N)C(O)=O MTCFGRXMJLQNBG-UWTATZPHSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 1
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- 229930182844 L-isoleucine Natural products 0.000 description 1
- 229930195722 L-methionine Natural products 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- CCUAQNUWXLYFRA-UHFFFAOYSA-N alanyl-asparagine Chemical compound CC(N)C(=O)NC(C(O)=O)CC(N)=O CCUAQNUWXLYFRA-UHFFFAOYSA-N 0.000 description 1
- 108010044940 alanylglutamine Proteins 0.000 description 1
- 229960002648 alanylglutamine Drugs 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000005277 cation exchange chromatography Methods 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical compound CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 description 1
- 238000011017 operating method Methods 0.000 description 1
- 235000016236 parenteral nutrition Nutrition 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 238000004007 reversed phase HPLC Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
时间(min) | 温度(℃) |
0 | 58 |
23.0 | 58 |
28.0 | 74 |
50.0 | 74 |
55.0 | 58 |
61.0 | 57 |
时间(min) | 缓冲液A | 缓冲液B | 再生液 | 缓冲泵流速(ml/min) |
0.00 | 100 | 0 | 0 | 0.45 |
3.00 | 100 | 0 | 0 | 0.45 |
5.00 | 87 | 13 | 0 | 0.45 |
7.00 | 87 | 13 | 0 | 0.45 |
9.00 | 91 | 9 | 0 | 0.45 |
13.00 | 85 | 15 | 0 | 0.45 |
14.00 | 84 | 16 | 0 | 0.45 |
15.00 | 84 | 16 | 0 | 0.45 |
20.00 | 80 | 20 | 0 | 0.45 |
25.00 | 67 | 33 | 0 | 0.45 |
29.00 | 20 | 80 | 0 | 0.45 |
31.00 | 20 | 80 | 0 | 0.45 |
32.00 | 0 | 100 | 0 | 0.45 |
45.00 | 0 | 100 | 0 | 0.45 |
45.10 | 0 | 0 | 100 | 0.45 |
48.10 | 0 | 0 | 100 | 0.45 |
48.20 | 100. | 0 | 0 | 0.45 |
61.20 | 100 | 0 | 0 | 0.45 |
61.30 | 100 | 0 | 0 | 0.00 |
氨基酸 | 计算的含量(%) |
门冬氨酸 | 98.8 |
苏氨酸 | 103.4 |
丝氨酸 | 97.4 |
谷氨酸 | 97.3 |
脯氨酸 | 101.6 |
丙氨酸 | 100.0 |
缬氨酸 | 99.8 |
甘氨酰谷氨酰胺 | 105.3 |
甲硫氨酸 | 95.6 |
异亮氨酸 | 99.5 |
亮氨酸 | 103.0 |
苯丙氨酸 | 99.1 |
组氨酸 | 99.1 |
醋酸赖氨酸 | 99.1 |
精氨酸 | 99.7 |
出峰顺序 | 氨基酸名称 | 保留时间(min) |
1 | 门冬氨酸 | 7.824 |
2 | 苏氨酸 | 10.024 |
3 | 丝氨酸 | 10.872 |
4 | 谷氨酸 | 11.944 |
5 | 脯氨酸 | 13.8 |
6 | 丙氨酸 | 18.944 |
7 | 缬氨酸 | 20.36 |
8 | GQ | 21.552 |
9 | 甲硫氨酸 | 22.992 |
10 | 异亮氨酸 | 25.672 |
11 | 亮氨酸 | 26.904 |
12 | 苯丙氨酸 | 31.768 |
13 | 组氨酸 | 36.64 |
14 | 醋酸赖氨酸 | 40.128 |
15 | 精氨酸 | 43.648 |
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410604021.4A CN104280475B (zh) | 2014-10-30 | 2014-10-30 | 复方氨基酸(15)双肽(2)注射液氨基酸和甘氨酰谷氨酰胺含量检测方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410604021.4A CN104280475B (zh) | 2014-10-30 | 2014-10-30 | 复方氨基酸(15)双肽(2)注射液氨基酸和甘氨酰谷氨酰胺含量检测方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104280475A CN104280475A (zh) | 2015-01-14 |
CN104280475B true CN104280475B (zh) | 2017-02-08 |
Family
ID=52255563
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410604021.4A Active CN104280475B (zh) | 2014-10-30 | 2014-10-30 | 复方氨基酸(15)双肽(2)注射液氨基酸和甘氨酰谷氨酰胺含量检测方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104280475B (zh) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106706787B (zh) * | 2016-12-26 | 2019-01-15 | 国药集团国瑞药业有限公司 | 一种注射用赖氨匹林中赖氨酸含量的检测方法及应用 |
CN107632094A (zh) * | 2017-09-18 | 2018-01-26 | 成都中医药大学 | 一种测定黄连中游离氨基酸的方法 |
CN110596294B (zh) * | 2019-10-18 | 2021-07-06 | 山东威高药业股份有限公司 | 一种甘氨酰-d-谷氨酰胺的高效液相检测方法 |
CN110702819B (zh) * | 2019-11-08 | 2022-09-06 | 浙江美测医药科技有限公司 | 一种用高效液相色谱法分离测定含多个手性中心的多肽手性异构体的方法 |
CN111323503B (zh) * | 2020-03-12 | 2022-10-11 | 河北科星药业有限公司 | 复方氨基酸注射液含量测定方法 |
CN112526141B (zh) * | 2020-11-23 | 2024-07-05 | 福建傲农生物科技集团股份有限公司 | 一种谷氨酰胺以及同时测定样品中谷氨酰胺和天冬酰胺的方法 |
CN112697934A (zh) * | 2020-12-10 | 2021-04-23 | 武汉久安药业有限公司 | 一种复方氨基酸注射液中焦谷氨酸含量的检测方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103134892A (zh) * | 2011-11-30 | 2013-06-05 | 天津金耀集团有限公司 | 复方氨基酸(15)双肽(2)注射液的分析方法 |
CN102749397A (zh) * | 2012-07-19 | 2012-10-24 | 天津金耀集团有限公司 | 一种复方氨基酸(15)双肽(2)注射液的分析方法 |
CN102841158B (zh) * | 2012-09-26 | 2014-03-12 | 贵州省烟草科学研究所 | 一种用氨基酸分析仪测定卷烟主流烟气中的氨的方法 |
-
2014
- 2014-10-30 CN CN201410604021.4A patent/CN104280475B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN104280475A (zh) | 2015-01-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104280475B (zh) | 复方氨基酸(15)双肽(2)注射液氨基酸和甘氨酰谷氨酰胺含量检测方法 | |
CN107907603B (zh) | 一种测定氨基酸类注射液色氨酸有关物质的测定方法 | |
Shimbo et al. | Automated precolumn derivatization system for analyzing physiological amino acids by liquid chromatography/mass spectrometry | |
CN102749397A (zh) | 一种复方氨基酸(15)双肽(2)注射液的分析方法 | |
CN103163226A (zh) | 30种氨基酸同时定量检测方法及试剂盒制备 | |
CN104678044A (zh) | 利用反相高效液相色谱检测茶叶中游离氨基酸的方法 | |
CN104391053B (zh) | 一种同时测定地龙注射剂中五种氨基酸含量的pr-hplc测定方法 | |
CN104977372B (zh) | 高效液相色谱法测定塞来昔布原料药中对磺酰胺基苯肼盐酸盐含量的方法 | |
CN106841408B (zh) | 一种氨基酸注射液中蛋氨酸亚砜的快速检测方法 | |
CN109991348A (zh) | 一种艾本那肽前体中三乙胺残留的gc检测方法 | |
CN102288687B (zh) | 一种门冬氨酸鸟氨酸杂质的分析检测方法 | |
Brückner | Enantiomeric resolution of N-methyl-α-amino acids and α-alkyl-α-amino acids by ligand-exchange chromatography | |
CN108931598A (zh) | 基于lc-ms/ms的血清中40种氨基化合物的检测试剂盒 | |
CN105319309A (zh) | 一种甘氨酰-l-谷氨酰胺手性异构体的分离检测方法 | |
CN103134892A (zh) | 复方氨基酸(15)双肽(2)注射液的分析方法 | |
CN112946099B (zh) | 一种氨基酸葡萄糖注射液中有关物质的检测方法 | |
CN108663448A (zh) | 一种复方氨基酸注射液中有关物质的检测方法 | |
CN110297044A (zh) | 一种识别氨基酸及肽类化合物绝对构型和光学纯度的方法 | |
CN106338561A (zh) | 一种丙谷二肽中间体的定量检测方法 | |
CN105223280A (zh) | 一种乌鸡增乳制剂中氨基酸含量的测定方法 | |
CN108828085A (zh) | 一种转移因子胶囊的总氨基酸定量检测方法 | |
CN104897841A (zh) | 高效液相色谱法测定塞来昔布胶囊中对磺酰胺基苯肼盐酸盐含量的方法 | |
CN104897832B (zh) | 转移因子溶液及其制剂中游离氨基酸含量的高效液相色谱检测方法 | |
CN101929988B (zh) | 一种用高效液相色谱法测定非布索坦有关物质的方法 | |
CN103293236A (zh) | 一种测定丙胺酰谷氨酰胺含量的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CB03 | Change of inventor or designer information |
Inventor after: Hu Fei Inventor after: Wan Yangyu Inventor after: Luo Chengxin Inventor after: Wu Xiaoyu Inventor after: Ran Longxing Inventor after: Zhu Lin Inventor after: Lei Xiangjie Inventor after: Wang Hui Inventor after: Liu Sichuan Inventor after: Tan Hongbo Inventor after: Liu Wenjun Inventor after: Ge Junyou Inventor before: Deng Maolin Inventor before: Liu Wenjun Inventor before: Luo Chengxin Inventor before: Wu Xiaoyu Inventor before: Chen Kezhi Inventor before: Wu Dan Inventor before: He Ying Inventor before: Tan Hongbo Inventor before: Liu Sichuan Inventor before: Cheng Zhipeng Inventor before: Ge Junyou Inventor before: Wan Yangyu Inventor before: Rao Xiaoli |
|
COR | Change of bibliographic data | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20150114 Assignee: HEILONGJIANG KELUN PHARMACEUTICAL Co.,Ltd. Assignor: Sichuan Kelun Pharmaceutical Co.,Ltd. Contract record no.: X2021510000039 Denomination of invention: Determination of amino acid and glycyl glutamine in compound amino acid (15) dipeptide (2) injection Granted publication date: 20170208 License type: Common License Record date: 20210924 |
|
EE01 | Entry into force of recordation of patent licensing contract |